JP2008543890A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008543890A5 JP2008543890A5 JP2008517321A JP2008517321A JP2008543890A5 JP 2008543890 A5 JP2008543890 A5 JP 2008543890A5 JP 2008517321 A JP2008517321 A JP 2008517321A JP 2008517321 A JP2008517321 A JP 2008517321A JP 2008543890 A5 JP2008543890 A5 JP 2008543890A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- pharmaceutical composition
- composition
- immunogenic
- mycobacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500924 | 2005-06-23 | ||
| DKPA200500924 | 2005-06-23 | ||
| DKPA200501393 | 2005-10-05 | ||
| DKPA200501393 | 2005-10-05 | ||
| PCT/DK2006/000356 WO2006136162A2 (en) | 2005-06-23 | 2006-06-20 | Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013001657A Division JP2013121959A (ja) | 2005-06-23 | 2013-01-09 | 改良された結核ワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008543890A JP2008543890A (ja) | 2008-12-04 |
| JP2008543890A5 true JP2008543890A5 (cg-RX-API-DMAC7.html) | 2009-12-24 |
| JP5219808B2 JP5219808B2 (ja) | 2013-06-26 |
Family
ID=37134239
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517321A Expired - Fee Related JP5219808B2 (ja) | 2005-06-23 | 2006-06-20 | 改良された結核ワクチン |
| JP2013001657A Pending JP2013121959A (ja) | 2005-06-23 | 2013-01-09 | 改良された結核ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013001657A Pending JP2013121959A (ja) | 2005-06-23 | 2013-01-09 | 改良された結核ワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US7968105B2 (cg-RX-API-DMAC7.html) |
| EP (4) | EP1910409A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5219808B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR101035053B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102836425B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006261445B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0612833A2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2836319A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2647070T3 (cg-RX-API-DMAC7.html) |
| IL (3) | IL188222A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007016165A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006136162A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19529931C1 (de) | 1995-08-02 | 1997-04-03 | Mannesmann Ag | Plattenkokille zur Erzeugung von Strängen aus Stahl |
| AU2003242504A1 (en) * | 2002-07-13 | 2004-02-02 | Statens Serum Institut | Therapeutic tuberculosis vaccines |
| PL2136836T3 (pl) * | 2007-04-04 | 2017-07-31 | Infectious Disease Research Institute | Kompozycje immunogenne zawierające polipeptydy prątka gruźlicy i produkty ich fuzji |
| WO2008128065A2 (en) * | 2007-04-12 | 2008-10-23 | Jennifer Lighter | Tuberculosis vaccine and method of using same |
| US8563009B2 (en) * | 2007-06-29 | 2013-10-22 | Statens Serum Institut | Use of monomycolyl glycerol (MMG) as an adjuvant |
| EP2244720A4 (en) * | 2008-01-11 | 2013-01-16 | Us Gov Health & Human Serv | POLYPEPTIDE VACCINE AND VACCINE STRATEGY AGAINST MYCOBACTERIUM |
| US20100015171A1 (en) * | 2008-07-15 | 2010-01-21 | Statens Serum Institute | Vaccines comprising tb 10.4 |
| HUE031044T2 (en) * | 2008-07-25 | 2017-06-28 | Glaxosmithkline Biologicals Sa | Polypeptides, polynucleotides and compositions for use in the treatment of latent tuberculosis |
| ES2588183T3 (es) * | 2009-03-31 | 2016-10-31 | Japan As Represented By Director-General Of National Institute Of Infectious Diseases | Procedimiento para la prevención de la gripe utilizando una vacuna para administración intranasal |
| CN102413837B (zh) * | 2009-04-24 | 2015-11-25 | 国立血清研究所 | 预防再激活的结核病tb疫苗 |
| CN106421743A (zh) * | 2009-07-29 | 2017-02-22 | 贝恩德·赫尔穆特·阿达姆·雷姆 | 聚合物微粒及其用途 |
| SG11201500171YA (en) | 2012-07-10 | 2015-02-27 | Transgene Sa | Mycobacterial antigen vaccine |
| RU2520078C1 (ru) * | 2013-04-25 | 2014-06-20 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "НИИЭМ им. Н.Ф. Гамалеи" Минздрава России) | СПОСОБ ПОЛУЧЕНИЯ ИММУНОГЕННОЙ КОМПОЗИЦИИ НА ОСНОВЕ ГИБРИДНОГО БЕЛКА Ag85A-DBD И ДЕКСТРАНА, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pAg85A-DBD, ШТАММ Escherichia coli [pREP4, pAg85A-DBD], ХИМЕРНЫЙ БЕЛОК Ag85A-DBD |
| RU2520737C1 (ru) * | 2013-04-25 | 2014-06-27 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии имени почётного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "НИИЭМ им. Н.Ф. Гамалеи" Минздрава России) | СПОСОБ ПОЛУЧЕНИЯ ИММУНОГЕННОЙ КОМПОЗИЦИИ НА ОСНОВЕ ГИБРИДНОГО БЕЛКА pESAT6-DBD И ДЕКСТРАНА, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pESAT6-DBD, ШТАММ Escherichia coli, ХИМЕРНЫЙ БЕЛОК ESAT6-DBD И ИХ ПРИМЕНЕНИЕ |
| RU2539026C1 (ru) * | 2013-06-11 | 2015-01-10 | Федеральное государственное бюджетное учреждение "Центральный научно-исследовательский институт туберкулеза" Российской академии медицинских наук | РЕКОМБИНАНТНАЯ ПЛАЗМИДА pESAT6-CFP10-DBD, РЕКОМБИНАНТНЫЙ ШТАММ Escherichia coli M15 [pREP4, pESAT6-CFP10-DBD], СПОСОБ ПОЛУЧЕНИЯ, ИММОБИЛИЗАЦИИ, КОНЦЕНТРИРОВАНИЯ И ОЧИСТКИ РЕКОМБИНАНТНОГО БЕЛКА ESAT6-CFP10-DBD НА ДЕКСТРАНЕ, РЕКОМБИНАНТНЫЙ БЕЛОК ESAT6-CFP10-DBD И ИММУНОГЕННАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ БЕЛОК ESAT6-CFP10-DBD |
| WO2014210018A1 (en) | 2013-06-25 | 2014-12-31 | Aeras Global Tb Vaccine Foundation | Tuberculosis compositions and methods of using the same |
| CN106103471B (zh) * | 2014-01-09 | 2020-01-07 | 特兰斯吉恩股份有限公司 | 异源寡聚分枝杆菌抗原的融合 |
| WO2017218867A1 (en) * | 2016-06-16 | 2017-12-21 | Aeras | Tuberculosis compositions and methods of treating or preventing tuberculosis |
| CN107970444B (zh) * | 2016-10-25 | 2022-03-01 | 中国人民解放军第三0九医院 | 复合佐剂及含有该复合佐剂的疫苗 |
| PH12021553146A1 (en) * | 2019-06-14 | 2024-04-22 | Statens Seruminstitut | Fusion proteins for tuberculosis vaccines |
| EP4217066A4 (en) * | 2020-09-23 | 2024-10-23 | The General Hospital Corporation | BCG VACCINES TO PREVENT COVID-19 AND OTHER INFECTIOUS DISEASES |
| KR102709729B1 (ko) * | 2020-12-04 | 2024-09-25 | 주식회사 제넥신 | 결핵의 예방 또는 치료용 약학적 조성물 |
| CN115598041B (zh) * | 2021-07-07 | 2025-08-19 | 中国科学院微生物研究所 | 结核鉴别诊断细胞因子及其在结核感染风险评估中的应用 |
| KR20240153581A (ko) | 2022-02-21 | 2024-10-23 | 스태튼스 세룸 인스티튜트 | 신규한 양이온 어주번트 조성물 |
| CN117531001A (zh) * | 2023-11-15 | 2024-02-09 | 首都医科大学附属北京胸科医院 | 结核分枝杆菌毒素抗毒素系统及其相关应用 |
| CN118108815B (zh) * | 2024-04-23 | 2024-07-23 | 成都康华生物制品股份有限公司 | 结核分枝杆菌多免疫原抗原、编码其的mRNA、应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1331C (da) | 1897-11-15 | Hans Daae | Militær- og Skilygte. | |
| US4599230A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4599231A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4608251A (en) | 1984-11-09 | 1986-08-26 | Pitman-Moore, Inc. | LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues |
| US4601903A (en) | 1985-05-01 | 1986-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease |
| US6641814B1 (en) | 1997-04-02 | 2003-11-04 | Statens Serum Institut | Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis |
| WO1996009320A1 (fr) * | 1994-09-20 | 1996-03-28 | Hitachi Chemical Company, Ltd. | Polypeptide antigenique de chlamydia pneumoniae |
| EP1741718A3 (en) | 1995-06-07 | 2007-03-28 | Sanofi Pasteur Inc. | Expression of lipoproteins |
| US20040018574A1 (en) * | 1998-08-25 | 2004-01-29 | Marcel Behr | Molecular differences between species of the M. tuberculosis complex |
| JP2003510326A (ja) | 1999-09-30 | 2003-03-18 | ニューロジェン・コーポレーション | アミノ置換ピラゾロ［１，５−ａ］−１，５−ピリミジン類及びピラゾロ［１，５−ａ］−１，３，５−トリアジン類 |
| AU2001250294A1 (en) | 2000-04-19 | 2001-10-30 | Statens Serum Institut | Tuberculosis antigens and methods of use thereof |
| AU2001271963A1 (en) | 2000-07-10 | 2002-01-21 | Colorado State University Research Foundation | Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
| US20030180953A1 (en) * | 2000-12-29 | 2003-09-25 | Elitra Pharmaceuticals, Inc. | Gene disruption methodologies for drug target discovery |
| JP2005522980A (ja) * | 2001-04-23 | 2005-08-04 | エリトラ ファーマシューティカルズ，インコーポレイテッド | アスペルギルス・フミガーツス（Ａｓｐｅｒｇｉｌｌｕｓｆｕｍｉｇａｔｕｓ）の必須遺伝子の同定および使用方法 |
| EP1404706A2 (en) * | 2001-07-04 | 2004-04-07 | Health Protection Agency | Mycobacterial antigens expressed during latency |
| AU2003242504A1 (en) * | 2002-07-13 | 2004-02-02 | Statens Serum Institut | Therapeutic tuberculosis vaccines |
-
2006
- 2006-06-20 JP JP2008517321A patent/JP5219808B2/ja not_active Expired - Fee Related
- 2006-06-20 EP EP06753317A patent/EP1910409A2/en not_active Withdrawn
- 2006-06-20 AU AU2006261445A patent/AU2006261445B2/en not_active Ceased
- 2006-06-20 CA CA2836319A patent/CA2836319A1/en not_active Abandoned
- 2006-06-20 KR KR1020087001874A patent/KR101035053B1/ko not_active Expired - Fee Related
- 2006-06-20 EP EP11171143A patent/EP2380589A3/en not_active Withdrawn
- 2006-06-20 BR BRPI0612833-5A patent/BRPI0612833A2/pt not_active IP Right Cessation
- 2006-06-20 CN CN201210332759.0A patent/CN102836425B/zh not_active Expired - Fee Related
- 2006-06-20 ES ES09172905.3T patent/ES2647070T3/es active Active
- 2006-06-20 WO PCT/DK2006/000356 patent/WO2006136162A2/en not_active Ceased
- 2006-06-20 EP EP11171153A patent/EP2380590A3/en not_active Withdrawn
- 2006-06-20 KR KR1020107024618A patent/KR101188045B1/ko not_active Expired - Fee Related
- 2006-06-20 CA CA2612900A patent/CA2612900C/en not_active Expired - Fee Related
- 2006-06-20 MX MX2007016165A patent/MX2007016165A/es active IP Right Grant
- 2006-06-20 EP EP09172905.3A patent/EP2163255B1/en not_active Not-in-force
- 2006-06-20 US US11/993,199 patent/US7968105B2/en not_active Expired - Fee Related
-
2007
- 2007-12-18 IL IL188222A patent/IL188222A/en not_active IP Right Cessation
-
2011
- 2011-05-05 US US13/101,980 patent/US8101193B2/en not_active Expired - Fee Related
- 2011-12-22 US US13/335,133 patent/US8293250B2/en not_active Expired - Fee Related
-
2012
- 2012-09-20 US US13/623,733 patent/US8703151B2/en not_active Expired - Fee Related
- 2012-11-07 IL IL222914A patent/IL222914A0/en unknown
- 2012-11-07 IL IL222915A patent/IL222915A0/en unknown
-
2013
- 2013-01-09 JP JP2013001657A patent/JP2013121959A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008543890A5 (cg-RX-API-DMAC7.html) | ||
| JP2008539187A5 (cg-RX-API-DMAC7.html) | ||
| US11224646B2 (en) | Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis | |
| Ingolotti et al. | DNA vaccines for targeting bacterial infections | |
| JP2013507907A5 (cg-RX-API-DMAC7.html) | ||
| JP2008530245A5 (cg-RX-API-DMAC7.html) | ||
| US10004793B2 (en) | M.tuberculosis vaccines | |
| EP3013364B1 (en) | Tuberculosis compositions and methods of using the same | |
| KR20170072366A (ko) | 재활성화를 예방하기 위한 결핵 백신 | |
| BRPI0905725B1 (pt) | vacina e embalagem farmacêutica | |
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| JP2015524794A5 (cg-RX-API-DMAC7.html) | ||
| CN104736555A (zh) | 结核分枝杆菌疫苗 | |
| JP2017505605A5 (cg-RX-API-DMAC7.html) | ||
| Kaufmann | Tuberculosis vaccine development at a divide | |
| CN101745104A (zh) | 含有复合佐剂的结核亚单位疫苗 | |
| CN106237317A (zh) | 由结核分枝杆菌抗原组成的结核疫苗 | |
| CN101451145A (zh) | 基于t细胞表位的结核基因疫苗及其制备方法和应用 | |
| Mobed | DNA Based vaccines against Mycobacterium tuberculosis: recent progress in vaccine development and delivery system | |
| Avarvand et al. | The roles of latency-associated antigens in tuberculosis vaccines | |
| BR112012011395B1 (pt) | Uso de uma fonte de l3 e/ou l5 como uma vacina ou como um diagnóstico para uma doença parasítica | |
| Rivas-Santiago et al. | Novel approaches to tuberculosis prevention: DNA vaccines | |
| Li et al. | Improved humoral immunity against tuberculosis ESAT-6 antigen by chimeric DNA prime and protein boost strategy | |
| AU2006204382B2 (en) | Compositions for immunizing against mycobacterium | |
| ES2364698T3 (es) | Composición para inmunizar contra mycobacterium. |